LUXU_VIBHA
ID LUXU_VIBHA Reviewed; 114 AA.
AC P0C5S4; Q9ZBB6;
DT 13-NOV-2007, integrated into UniProtKB/Swiss-Prot.
DT 13-NOV-2007, sequence version 1.
DT 03-AUG-2022, entry version 42.
DE RecName: Full=Phosphorelay protein LuxU;
GN Name=luxU;
OS Vibrio harveyi (Beneckea harveyi).
OC Bacteria; Proteobacteria; Gammaproteobacteria; Vibrionales; Vibrionaceae;
OC Vibrio.
OX NCBI_TaxID=669;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, PHOSPHORYLATION AT HIS-58, AND
RP MUTAGENESIS OF HIS-58 AND HIS-103.
RC STRAIN=BB7;
RX PubMed=9922254; DOI=10.1128/jb.181.3.899-906.1999;
RA Freeman J.A., Bassler B.L.;
RT "Sequence and function of LuxU: a two-component phosphorelay protein that
RT regulates quorum sensing in Vibrio harveyi.";
RL J. Bacteriol. 181:899-906(1999).
RN [2]
RP STRUCTURE BY NMR, AND SUBUNIT.
RX PubMed=15740742; DOI=10.1016/j.jmb.2005.01.039;
RA Ulrich D.L., Kojetin D., Bassler B.L., Cavanagh J., Loria J.P.;
RT "Solution structure and dynamics of LuxU from Vibrio harveyi, a
RT phosphotransferase protein involved in bacterial quorum sensing.";
RL J. Mol. Biol. 347:297-307(2005).
CC -!- FUNCTION: Phosphorelay protein which receives sensory signals from LuxN
CC and LuxP and transmits them to LuxO, at low cell density. LuxN and LuxP
CC transfer a phosphoryl group to LuxU on His-58 and this phosphoryl group
CC is further transferred to LuxO. At high cell density, as LuxU could
CC function to establish an equilibrium between the aspartyl-phosphate of
CC LuxN and the aspartyl-phosphate of LuxO, LuxU transfers phosphate from
CC LuxO to LuxN (and probably LuxP) and finally phosphate is drained from
CC the system. {ECO:0000269|PubMed:9922254}.
CC -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:15740742}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; L26221; AAD12737.2; -; Genomic_DNA.
DR PDB; 1Y6D; NMR; -; A=1-114.
DR PDBsum; 1Y6D; -.
DR AlphaFoldDB; P0C5S4; -.
DR BMRB; P0C5S4; -.
DR SMR; P0C5S4; -.
DR iPTMnet; P0C5S4; -.
DR EvolutionaryTrace; P0C5S4; -.
DR GO; GO:0004672; F:protein kinase activity; IEA:UniProt.
DR GO; GO:0000160; P:phosphorelay signal transduction system; IEA:UniProtKB-KW.
DR DisProt; DP00292; -.
DR Gene3D; 1.20.120.160; -; 1.
DR InterPro; IPR036641; HPT_dom_sf.
DR InterPro; IPR008207; Sig_transdc_His_kin_Hpt_dom.
DR Pfam; PF01627; Hpt; 1.
DR SUPFAM; SSF47226; SSF47226; 1.
DR PROSITE; PS50894; HPT; 1.
PE 1: Evidence at protein level;
KW 3D-structure; Phosphoprotein; Two-component regulatory system.
FT CHAIN 1..114
FT /note="Phosphorelay protein LuxU"
FT /id="PRO_0000220141"
FT DOMAIN 19..114
FT /note="HPt"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00110"
FT MOD_RES 58
FT /note="Phosphohistidine"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00110,
FT ECO:0000269|PubMed:9922254"
FT MUTAGEN 58
FT /note="H->A: Constitutive luminescence."
FT /evidence="ECO:0000269|PubMed:9922254"
FT MUTAGEN 103
FT /note="H->A: No effect."
FT /evidence="ECO:0000269|PubMed:9922254"
FT TURN 4..9
FT /evidence="ECO:0007829|PDB:1Y6D"
FT HELIX 10..14
FT /evidence="ECO:0007829|PDB:1Y6D"
FT HELIX 16..40
FT /evidence="ECO:0007829|PDB:1Y6D"
FT TURN 41..44
FT /evidence="ECO:0007829|PDB:1Y6D"
FT HELIX 47..57
FT /evidence="ECO:0007829|PDB:1Y6D"
FT HELIX 59..67
FT /evidence="ECO:0007829|PDB:1Y6D"
FT TURN 68..70
FT /evidence="ECO:0007829|PDB:1Y6D"
FT HELIX 71..82
FT /evidence="ECO:0007829|PDB:1Y6D"
FT HELIX 84..88
FT /evidence="ECO:0007829|PDB:1Y6D"
FT TURN 90..92
FT /evidence="ECO:0007829|PDB:1Y6D"
FT TURN 94..99
FT /evidence="ECO:0007829|PDB:1Y6D"
FT HELIX 100..112
FT /evidence="ECO:0007829|PDB:1Y6D"
SQ SEQUENCE 114 AA; 12689 MW; E61DFCE6CB2C8D98 CRC64;
MNTDVLNQQK IEELSAEIGS DNVPVLLDIF LGEMDSYIGT LTELQGSEQL LYLKEISHAL
KSSAASFGAD RLCERAIAID KKAKANQLQE QGMETSEMLA LLHITRDAYR SWTN